In Accordance with code of Internal Procedure and Conduct of Regulating, Monitoring and Reporting of Trading by Employee and other connected person of the Company framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading ) Regulation, 2015 read with BSE Circular Ref. No. List/COMP//01/2019-20 dated 24 April, 2019, Chandra Bhagat Pharma has informed that the trading window for dealing in the securities of the company will be closed for all directors, officers and KMP (key managerial personal), designated employee of the company with immediate effect and would open 48 hours after the announcement of Financial Result for the half year ended on 30th September, 2021.
The above information is a part of company’s filings submitted to BSE.
